Regional brain volume change over the life-time course of schizophrenia

Journal of Psychiatric Research

Volumn 33, Issue 6, 1999, Pages 535-541

  Delisi, Lynn E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEVELOPMENT; BRAIN SIZE; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0032693906     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(99)00028-X     Document Type: Article

References (47)

1. Arnold S.E., Franz B.R., Gur R.E., Shapiro R.M., Moberg P.J., Trojanowski J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical hippocampal interactions. Am. J. Psychiatry. 152:1995;738-748.
2. Azmetia E.C., Whitaker-Azmitia P.M. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J. Clin. Psychiatry. 52:1991;4-16. Supplement.
3. Benes F.M., McSparren J., Bird E.D., San Giovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives General Psychiatry. 48:1991;996-1001.
4. Bowers M.B. Jr, Heninger G.R., Gerbode F. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients. Int. J. Neuropsychopharm. 8:1969;255-262.
5. Buckley P.F. Structural brain imaging in schizophrenia. Psychiatric Clinics of North America. 21:1998;77-92.
6. Crow T.J. Constraints on concepts of pathogenesis: Language and the speciation process as the key to the etiology of schizophrenia. Archives General Psychiatry. 52:1995;1011-1014.
7. Crow T.J. Is schizophrenia the price that Homo sapiens pays for language? Schizophrenia Research. 28:1997;127-141.
8. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., Frith C.D., Johnstone E.C., Owens D.G., Roberts G.W. Schizophrenia as an anomaly of development of cerebral asymmetry: a post-mortem study and a proposal concerning the genetic basis of the disorder. Archives General Psychiatry. 46:1989;1145-1150.
9. Davis K.L., Buchsbaum M.S., Shihabuddin L., Spiegel-Cohen J., Metzger M., Frecska E., Keefe R.S., Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biological Psychiatry. 43:1998;783-793.
10. DeGreef G., Ashtari M., Bogerts B., Bilder R.M., Jody D.N., Alvir J.M., Lieberman J.A. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Archives of General Psychiatry. 49:1992;531-537.
11. DeLisi L.E. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophrenia Research. 23:1997;119-129.
12. DeLisi L.E., Sakuma M., Ge S., Kushner M. Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psychiatry Research. 84:1998;75-88.
13. DeLisi L.E., Neckers L.M., Weinberger D.R., Wyatt R.J. Increased whole blood serotonin concentrations in chronic schizophrenic patients. Arch. General Psychiatry. 38:1981;647-650.
14. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research: Neuroimaging Section. 74:1997;129-140.
15. DeLisi L.E., Hoff A.L., Schwartz J., Shields G., Halthore S., Gupta S., Anand A. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biological Psychiatry. 29:1991;159-175.
16. DeLisi L.E., Tew W., Xie S-H., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., Grimson R. A prospective follow-up study of brain morphology and cognition in 1st episode schizophrenic patients. Biological Psychiatry. 38:1995;349-360.
17. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., St Peter H., Olney J.W. Age specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biological Psychiatry. 38:1995;788-796.
18. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatric Research. 17:1983;319-334.
19. Gillin J.C., Kaplan J., Stillman R., Wyatt R.J. The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine. Am. J. Psychiatry. 133:1976;203-208.
20. Golden N.H., Ashtari M., Kohn M.R., Patel M., Jacobsen M.S., Fletcher A., Shenker I.R. Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J. Pediatr. 128:1996;296-301.
21. Gur R.E., Cowell P., Turetsky B.J., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Arch. Gen. Psychiatry. 55:1998;145-152.
22. Haug J.O. Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatrica Scand. 66:1982;374-383.
23. Hirayasu Y., Shenton M.E., Salisbury D.F., Frumin M., Fischer I.A., Farrell D., Yurgelun-Todd D.A., Zarate C., McCarley R.W. Progressive change in posterior superior temporal gyrus in schizophrenia. Biological Psychiatry. 45:1999;117S.
24. Huber G. Pneumoencephalographische und psychopathologische bilder bei endogen psychosen. 1957;Springer, Berlin.
25. Hyde T.M., Ziegler J.C., Weinberger D.R. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis. Archives of Neurology. 49:1992;401-406.
26. Jacobsen L.K., Giedd J.N., Castellanos X., Vaituzis A.C., Hamberger S.D., Kumra S., Lenane M.C., Rapoport J.L. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am. J. of Psychiatry. 155:1998;678-685.
27. Keverne E.B. Genomic imprinting in the brain: commentary. Current Opinion in Neurobiology. 7:1997;463-468.
28. Lauriello J., Hoff A., Wieneke M.H., Blankfeld H., Faustman W.O., Rosenbloom M., Dement S., Sullivan E.V., Lim K.O., Pfefferbaum A. Similar extent of brain dysmorphology in severely ill women and men with schizophrenia. Am. J. of Psychiatry. 154:1997;819-825.
29. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia: a longitudinal magnetic resonance imaging study. Archives of General Psychiatry (in press) 1999.
30. Moore M.D., Nathan A.R., Elliot C., Laubach A. Encephalographic studies in mental disease. Am. J. of Psychiatry. 92:1935;43-67.
31. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder? British Medical Journal. 295:1987;681-682.
32. Nair T.R., Christensen J.D., Kingsbury S.J., Kumar N.G., Terry W.M., Garver D.L. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Research: Neuroimaging Section. 74:1997;141-150.
33. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Archives General Psychiatry. 53:1995;998-1005.
34. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
35. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives General Psychiatry. 47:1990;1023-1028.
36. Pfefferbaum A., Sullivan E.V., Mathalon D.H., Shear P.K., Rosenbloom M.J., Lim K.O. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alc. Clin. Exp. Res. 19:1995;1177-1191.
37. Randall P.L. Schizophrenia, abnormal connection, and brain evolution. Med. Hypotheses. 10:1983;247-280.
38. Rapoport J.L., Giedd J., Kumra S., Jacobsen L., Smith A., Lee P., Nelson J., Hamberger S. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Arch. Gen. Psychiatry. 54:1997;897-903.
39. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Archives General Psychiatry. 52:1995;805-818.
40. Torrey E.F., Peterson M.R. Slow and latent viruses in schizophrenia. Lancet. 2:1973;22-24.
41. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives General Psychiatry. 44:1987;660-669.
42. Weinberger D.L. Premorbid neuropathology in schizophrenia (letter). Lancet. ii:1988;445.
43. Weinberger D.R., DeLisi L.E., Perman G.P., Targum S.D., Wyatt R.J. CT scans in schizophreniform disorder and other acute psychiatric patients. Archives General Psychiatry. 37:1982;778-783.
44. Willner P. The dopamine hypothesis of schizophrenia: current status, future prospects. Int. Clin. Psychopharmacology. 12:1997;297-308.
45. Woods B.Y. Is schizophrenia a progressive neurodevelopmental disorder? toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670.
46. Woods B.T., Yurgelun-Todd D., Benes F.M., Frankenburg F.R., Pope H.C., McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation to clinical course. Biological Psychiatry. 27:1990;341-352.
47. Wooley D.W., Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. USA. 40:1954;228-231.